Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artivion (AORT) Cash & Equivalents (2016 - 2025)

Artivion's Cash & Equivalents history spans 17 years, with the latest figure at $64.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 21.41% year-over-year to $64.9 million; the TTM value through Dec 2025 reached $64.9 million, up 21.41%, while the annual FY2025 figure was $64.9 million, 21.41% up from the prior year.
  • Cash & Equivalents reached $64.9 million in Q4 2025 per AORT's latest filing, down from $73.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $73.4 million in Q3 2025 to a low of $30.8 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $51.6 million, with a median of $53.5 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 59.82% in 2021, then skyrocketed 66.11% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $55.0 million in 2021, then decreased by 28.47% to $39.4 million in 2022, then surged by 49.78% to $58.9 million in 2023, then decreased by 9.29% to $53.5 million in 2024, then increased by 21.41% to $64.9 million in 2025.
  • Per Business Quant, the three most recent readings for AORT's Cash & Equivalents are $64.9 million (Q4 2025), $73.4 million (Q3 2025), and $53.5 million (Q2 2025).